
<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Metabolic Disorders - DMB 2201</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="../styles/main.css">
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                
                <!-- TOP NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-06-protein-metabolism.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>
                        
                        <a href="topic-08-endocrinology.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 70%;"></div>
                        </div>
                        <span class="progress-text">Topic 7 of 10</span>
                    </div>
                </nav>

                <header class="document-header">
                    <div class="header-badge">
                        <span>‚ö†Ô∏è</span>
                        <span>Topic 07</span>
                    </div>
                    <h1 class="document-title">Metabolic Disorders</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Inborn Errors of Metabolism</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>35 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    
                    <!-- Section 1: Carbohydrate Metabolism Disorders -->
                    <section class="content-section" id="carbohydrate-disorders">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üç¨</span>
                                Disorders of Carbohydrate Metabolism
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>1. Galactosaemias</h3>
                            <p>A group of inherited enzyme deficiencies that feature elevation in the levels of blood galactose are referred to as galactosaemia. The classical form of galactosaemia is caused by "galactose-1-phosphate uridyltransferase" (GALT) gene defect and presents in infancy with failure to thrive, vomiting and intracranial hypertension. Other clinical symptoms may include mental retardation, jaundice, hepatosplenomegaly and cataracts. dose-dependent galactosuria. Three kinds of enzymes of the galactose metabolism viz. UDP-Hexose-1-Phosphate Uridyl Transferases, Galactokinase and 4-Epimerases have been implicated in these disorders characterized by galactosaemia with slight variations in the signs and symptoms.</p>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../assets/images/image-20251216-3f07e26a.jpeg" alt="Metabolism of Galactose (Deficiency of Enzymes in Red -> Galactosaemias)" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Metabolism of Galactose and Galactosaemias</figcaption>
                            </figure>

                            <p><strong>Diagnosis: Biochemical and urinary findings:</strong></p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Increase blood galactose level ‚Üë, Blood sugar level decreases ‚Üì (Hypoglycaemia), Inorganic P decreases ‚Üì, due to utilisation of PO4 for gal-1-p.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Increased excretion of galactose in urine ‚Üë, (galactosuria)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Albuminuria, and amino aciduria: amino acids excreted usually are serine, alanine and glycine.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Ophthalmoscopic examination shows presence of cataract galactosaemia</span></li>
                            </ul>

                            <details class="collapsible-section">
                                <summary class="collapsible-trigger">
                                    <span class="trigger-icon">‚ñ∂</span>
                                    <span class="trigger-text">2. Fructosuria & Intolerance</span>
                                </summary>
                                <div class="collapsible-content">
                                    <h4>Fructosuria (Hepatic Fructokinase Deficiency)</h4>
                                    <p>Fructosuria is a benign, asymptomatic defect of intermediary metabolism characterised by the presence of large amounts of fructose in urine sufficient to give a positive reducing sugar test. Small amounts of fructose occur in the urine of normal individuals ingesting a regular diet but amounts sufficient to give a positive test for reducing sugar in the routine examination occur only in essential fructosuria, familial fructose intolerance, and advanced liver disease.</p>
                                    
                                    <h4>Hereditary Fructose Intolerance (Fructosaemia)</h4>
                                    <p>Most of the cases of fructose intolerance are severely ill infants with recurrent hypoglycaemia and vomiting, occurring at the time of weaning when fructose or sucrose is added to the diet and resulting in marked malnutrition. <strong>Hyperuricaemia and hyperuricosuria are commonly associated features.</strong> The defect resides in aldolase B. In aldolase 'B'-deficient tissues, cytoplasmic accumulation of fructose-1-phosphate leads to sequestration of inorganic phosphate.</p>
                                    
                                    <figure class="content-figure" data-lightbox="true">
                                        <div class="figure-image-wrapper">
                                            <img src="../../../../assets/images/image-20251216-47e74bba.jpeg" alt="Metabolic defects in Fructosuria and Hereditary Fructose Intolerance" class="figure-image">
                                            <div class="figure-overlay">
                                                <span class="overlay-icon">üîç</span>
                                                <span class="overlay-text">Click to enlarge</span>
                                            </div>
                                        </div>
                                        <figcaption class="figure-caption">Fructose Metabolism Defects</figcaption>
                                    </figure>
                                </div>
                            </details>

                            <h3>3. Lactose Intolerance</h3>
                            <p>Lactose intolerance is the inability to digest lactose, a disaccharide found in milk and other dairy products. It is caused by a deficiency of the enzyme lactase.</p>
                            <p><strong>Biochemical:</strong> Lactose cannot be completely digested and absorbed in the small intestine and passes into the large intestine, where bacteria convert it to toxic products that cause abdominal cramps and diarrhoea. The problem is further complicated because undigested lactose and its metabolites increase the osmolarity of the intestinal contents, favouring the retention of water in the intestine.</p>

                            <h3>4. Glucose-6-Phosphate Dehydrogenase Deficiency</h3>
                            <p>Glucose-6-phosphate dehydrogenase (G6PD) deficiency increases the vulnerability of erythrocytes to oxidative stress. Clinical presentations include acute hemolytic anemia, chronic hemolytic anaemia, neonatal hyperbilirubinaemia, and an absence of clinical symptoms.</p>
                            
                            <p><strong>Biochemical:</strong> G6PD catalyses nicotinamide adenine dinucleotide phosphate (NADP) to its reduced form, NADPH, in the pentose phosphate pathway. NADPH protects cells from oxidative damage. Because erythrocytes do not generate NADPH in any other way, they are more susceptible than other cells to destruction from oxidative stress.</p>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üíä</span>
                                    <span class="table-title">Medications to Avoid in G6PD Deficiency</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Drug name</th>
                                                <th>Use</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr><td>Primaquine</td><td>Antimalaria agent</td></tr>
                                            <tr><td>Dapsone</td><td>Antimicrobial for leprosy</td></tr>
                                            <tr><td>Methylene blue</td><td>Antidote for methemoglobinaemia</td></tr>
                                            <tr><td>Nitrofurantoin</td><td>Antibiotic for UTI</td></tr>
                                            <tr><td>Sulfamethoxazole</td><td>Antibiotic (Bactrim, septra)</td></tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <h3>5. Glycogen Storage Diseases (GSD)</h3>
                            <p>These are a group of inherited disorders associated with glycogen metabolism, familial in incidence and characterised by deposition of normal and abnormal type and quantities of glycogen in the tissues.</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Type / Name</th>
                                            <th>Deficient Enzyme</th>
                                            <th>Structure of Glycogen</th>
                                            <th>Clinical Features</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Type I (Von Gierke)</strong></td>
                                            <td>G-6-phosphatase</td>
                                            <td>Normal</td>
                                            <td>Hypoglycaemia, Ketosis, Acidosis, Hepatomegaly, Hyperuricaemia</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Type II (Pompe's)</strong></td>
                                            <td>Acid Maltase (Lysosomal)</td>
                                            <td>Normal</td>
                                            <td>Cardiomegaly, Muscle hypotonia, No Hypoglycaemia. Fatal in infancy.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Type III (Limit Dextrinosis)</strong></td>
                                            <td>Debranching enzyme</td>
                                            <td>Abnormal (Short outer branches)</td>
                                            <td>Moderate Hypoglycaemia, Hepatomegaly, Progressive myopathy</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Type IV (Amylopectinosis)</strong></td>
                                            <td>Branching enzyme</td>
                                            <td>Abnormal (Long unbranched chains)</td>
                                            <td>Hepatosplenomegaly, Cirrhosis, Hepatic failure</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Type V (McArdle's)</strong></td>
                                            <td>Muscle Phosphorylase</td>
                                            <td>Normal</td>
                                            <td>Muscle cramps on exercise, weakness. Blood sugar ‚Üë after glucagon (liver unaffected)</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Type VI (Her's)</strong></td>
                                            <td>Liver Phosphorylase</td>
                                            <td>Normal</td>
                                            <td>Hypoglycaemia, Mild acidosis, Hepatomegaly</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../assets/images/image-20251216-24592e7a.jpeg" alt="Metabolic blocks causing glycogen storage diseases" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">GSD Metabolic Blocks</figcaption>
                            </figure>
                        </div>
                    </section>

                    <!-- Section 2: Protein Metabolism Disorders -->
                    <section class="content-section" id="protein-disorders">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü•©</span>
                                Disorders of Protein Metabolism
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>1. Phenylketonuria (PKU)</h3>
                            <p>Phenylketonuria is an inborn error of metabolism resulting from a deficient activity of <strong>phenylalanine hydroxylase</strong> (EC 1. 14.16.1) and is characterized by hyperphenylalaninemia and mental retardation. The clinical features include a 'mousy' odor in urine; light pigmentation; peculiarities of gait, stance, and sitting posture; eczema; and epilepsy.</p>
                            
                            <p>The basic biochemical abnormality is the block at the conversion of phenylalanine to tyrosine. The resultant accumulation of phenylalanine and its alternate metabolic products i.e. (phenyl pyruvic acid, phenyl lactic acid and phenyl acetic acid) along with the resultant deficiency of tyrosine contributes to most of the clinical features.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../assets/images/image-20251216-e64f6402.jpeg" alt="Hydroxylation of phenylalanine and possible enzymes responsible for phenylketonuria" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Phenylalanine Metabolism Defects</figcaption>
                            </figure>

                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üß™</span>
                                    <h4 class="callout-title">Diagnosis of PKU</h4>
                                </div>
                                <div class="callout-content">
                                    <ul class="enhanced-list">
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content"><strong>Blood Levels:</strong> Normal blood phenylalanine is <span class="math-inline">58+/- 15 \mu M/l</span>. In untreated PKU, levels as high as <span class="math-inline">2.4 mM/l</span> can be found.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content"><strong>Ferric Chloride Test:</strong> Urine turns transient green or blue on adding ferric chloride due to phenylpyruvic acid.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content"><strong>Guthrie's Test:</strong> Bacterial inhibition assay using B. subtilis.</span></li>
                                    </ul>
                                </div>
                            </div>

                            <h3>2. Tyrosinemias</h3>
                            <p>Tyrosinemias are a group of inherited disorders characterized by levels of amino acid tyrosine and their catabolic intermediates in blood and their excretion in urine.</p>
                            
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>Tyrosinemia Type I (Hepatorenal):</strong> Deficiency of <strong>Fumarylacetoacetase</strong>. Presents with liver failure, cabbage-like odor, and renal tubular damage.
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>Tyrosinemia Type II (Oculocutaneous):</strong> Deficiency of <strong>Tyrosine Aminotransferase</strong>. Characterized by corneal ulcers and painful keratoses of palms/soles.
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>Tyrosinemia Type III:</strong> Deficiency of <strong>p-hydroxyphenylpyruvate dioxygenase</strong>. Rare, mild mental retardation, no liver damage.
                                    </span>
                                </li>
                            </ul>

                            <h3>3. Alkaptonuria</h3>
                            <p>(Homogentisic Acid Oxidase Deficiency). The manifestations are urine that turns dark on standing and alkalinization, black ochronotic pigmentation of cartilage and collagenous tissues, and arthritis, especially characteristic in the spine. Homogentisic acid accumulates and oxidizes to Benzoquinone Acetic Acid (BQA) which deposits in tissues.</p>

                            <h3>4. Homocystinuria</h3>
                            <p>(Cystathionine <span class="math-inline">\beta</span>-Synthase Deficiency). Characterized by dislocation of eye lenses (ectopia lentis), spinal osteoporosis, and thromboembolic events (recurrent strokes). Mild to moderate mental retardation is common. Homocysteine accumulates in plasma and is excreted in urine.</p>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../assets/images/image-20251216-8f9b50a5.jpeg" alt="Metabolism of Methionine and Homocysteinuria" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Methionine Metabolism</figcaption>
                            </figure>

                            <h3>5. Maple Syrup Urine Disease (MSUD)</h3>
                            <p>(Branched-Chain Ketoaciduria). Defect in <strong>Branched-Chain Alpha-Keto Acid Dehydrogenase</strong>. Leads to accumulation of branched-chain keto acids (from Leucine, Isoleucine, Valine). Clinical features: mental retardation, feeding problems, and a <strong>maple syrup odour to the urine</strong>.</p>

                            <h3>6. Albinism</h3>
                            <p>Arises from inherited defects in pigment cells (melanocytes) of eye and skin. Melanin is synthesized from phenylalanine/tyrosine through DOPA. <strong>Tyrosinase-negative</strong> albinos completely lack visual pigment (mutation in tyrosinase gene). <strong>Tyrosinase-positive</strong> have normal enzyme activity in vitro but cannot act in vivo (transport defect).</p>
                        </div>
                    </section>

                    <!-- Section 3: Lipid Metabolism Disorders -->
                    <section class="content-section" id="lipid-disorders">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü•ë</span>
                                Disorders of Lipid Metabolism
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Hyperlipidaemia (Hyperlipoproteinaemias)</h3>
                            <p>Fredrickson classification based on change in plasma lipoproteins:</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Type</th>
                                            <th>Defect/Deficiency</th>
                                            <th>Lipid Elevation</th>
                                            <th>Clinical Features</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Type I</strong></td>
                                            <td>Lipoprotein lipase or Apo-C II</td>
                                            <td>Chylomicrons ‚Üë (Triglycerides ‚Üë)</td>
                                            <td>Eruptive xanthomas, abdominal pain, lipaemia retinalis, pancreatitis. Creamy layer on top of serum.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Type IIa</strong></td>
                                            <td>LDL receptors</td>
                                            <td>LDL ‚Üë (Cholesterol ‚Üë)</td>
                                            <td>Tendinous/tuberous xanthomas, corneal arcus, premature atherosclerosis.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Type IIb</strong></td>
                                            <td>Combined defect</td>
                                            <td>LDL ‚Üë and VLDL ‚Üë (Chol & TG ‚Üë)</td>
                                            <td>Combined hyperlipidaemia features.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Type III</strong></td>
                                            <td>Remnant removal (Dys-Œ≤)</td>
                                            <td>IDL ‚Üë (Broad Œ≤ band)</td>
                                            <td>Palmar xanthomas, atherosclerosis.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Type IV</strong></td>
                                            <td>Endogenous TG synthesis</td>
                                            <td>VLDL ‚Üë (Triglycerides ‚Üë)</td>
                                            <td>Coronary artery disease, obesity, glucose intolerance. Turbid serum.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Type V</strong></td>
                                            <td>Combined Type I & IV</td>
                                            <td>Chylomicrons ‚Üë & VLDL ‚Üë</td>
                                            <td>Eruptive xanthomas, pancreatitis. Creamy layer + turbid infranate.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../assets/images/image-20251216-8f8affaa.jpeg" alt="Lipid Disorder Patterns" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Visual patterns of Hyperlipidaemia</figcaption>
                            </figure>
                        </div>
                    </section>

                    <!-- Section 4: Purine and Pyrimidine Disorders -->
                    <section class="content-section" id="purine-disorders">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                Purine and Pyrimidine Disorders
                            </h2>
                        </div>

                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>Lesch-Nyhan Syndrome:</strong> X-linked recessive defect of <strong>hypoxanthine-guanine phosphoribosyltransferase (HGPRT)</strong>. Leads to increased purine salvage pathway from PRPP. Results in severe gout, renal failure, spasticity and <strong>tendency for self-mutilation</strong>.
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>Adenosine Deaminase Deficiency:</strong> Associated with severe immunodeficiency (SCID) where both T cells and B cells are deficient. Accumulation of deoxyribonucleotides inhibits DNA synthesis.
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>Primary metabolic gout:</strong> Inherited metabolic defect leading to excessive rate of conversion of glycine to uric acid.
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>Orotic Aciduria:</strong> Type I is due to defect in <strong>orotate phosphoribosyltransferase</strong> and <strong>OMP decarboxylase</strong>. Causes megaloblastic anemia and accumulation of orotate.
                                    </span>
                                </li>
                            </ul>
                        </div>
                    </section>

                    <!-- Key Points Summary -->
                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Key Points</h3>
                            </div>
                            <ul class="key-points-list">
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Galactosaemia</strong> presents with vomiting, jaundice, and cataracts due to galactose-1-phosphate uridyltransferase deficiency.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Von Gierke Disease (GSD I)</strong> is caused by <strong>Glucose-6-phosphatase</strong> deficiency leading to severe hypoglycaemia and hepatomegaly.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Phenylketonuria (PKU)</strong> results from <strong>phenylalanine hydroxylase</strong> deficiency; untreated it causes mental retardation and a mousy urine odor.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Alkaptonuria</strong> is characterized by dark urine on standing and ochronosis (black pigmentation of cartilage).</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Maple Syrup Urine Disease</strong> presents with a characteristic maple syrup odor in urine due to branched-chain ketoaciduria.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Lesch-Nyhan Syndrome</strong> is an X-linked disorder of HGPRT deficiency causing self-mutilation and gout.</p>
                                </li>
                            </ul>
                        </div>
                    </aside>
                </main>

                <!-- BOTTOM NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-06-protein-metabolism.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>
                        
                        <a href="topic-08-endocrinology.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 70%;"></div>
                        </div>
                        <span class="progress-text">Topic 7 of 10</span>
                    </div>
                </nav>

            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div id="lightbox" class="lightbox-modal" hidden aria-hidden="true" role="dialog" aria-label="Image viewer">
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>
